{
  "claim_id": "claim_000",
  "claim": "Flublok contains 45 micrograms (mcg) of HA per strain vs 15 mcg of HA per strain in a standard-dose influenza vaccine.",
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 73
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2,
    "error": null
  },
  "supporting_snippets": [
    {
      "id": 2,
      "quote": "Across three clinical trials (Studies 2 \u2013 4, Tables 2 and 3) a total of 2050 adults age 50 years and older received Flublok and 2048 received a U.S.-licensed trivalent inactivated in\ufb02uenza vaccine (IIV3) comparator.",
      "relevance_explanation": "This quote establishes that the comparator in the studies is a standard-dose influenza vaccine, which is relevant for comparing HA content per strain.",
      "location": {
        "start": 3847,
        "end": 4063,
        "page_index": 1,
        "page_number": 2
      }
    },
    {
      "id": 3,
      "quote": "Data from a randomized, controlled trial demonstrated that children 6 months to less than 3 years of age had diminished hemagglutinin inhibition (HI) responses to Flublok compared to a U.S.-licensed in\ufb02uenza vaccine approved for use in this population, strongly suggesting that Flublok would not be effective in children younger than 3 years of age (6).",
      "relevance_explanation": "This quote references a U.S.-licensed influenza vaccine as a comparator, which is typically a standard-dose vaccine containing 15 mcg HA per strain, supporting the context for the claim.",
      "location": {
        "start": 17134,
        "end": 17475,
        "page_index": 2,
        "page_number": 3
      }
    }
  ],
  "model_used": "gpt-4.1"
}